Journal ArticleDOI
Performance of integrated FDG PET/contrast-enhanced CT in the diagnosis of recurrent colorectal cancer: Comparison with integrated FDG PET/non-contrast-enhanced CT and enhanced CT.
Kazuhiro Kitajima,Kazuhiro Kitajima,Kazuhiro Kitajima,Koji Murakami,Erena Yamasaki,Yasushi Domeki,Masahiro Tsubaki,Masakatsu Sunagawa,Yasushi Kaji,Narufumi Suganuma,Kazuro Sugimura +10 more
Reads0
Chats0
TLDR
Integrated PET/contrast-enhanced CT is an accurate modality for assessing colorectal cancer recurrence and led to changes in the subsequent appropriate therapy.Abstract:
Purpose
The purpose of this study is to evaluate the accuracy of 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography (FDG-PET)/computed tomography (CT) with intravenous contrast for depiction of recurrent pancreatic cancer, compared with PET/non-enhanced CT and CT.read more
Citations
More filters
Journal ArticleDOI
Metabolic positron emission tomography imaging in cancer detection and therapy response.
TL;DR: Fluorine 18-fluorodeoxyglucose PET imaging (FDG-PET) is widely used clinically for tumor imaging due to increased glucose metabolism in most types of tumors, and has been shown to improve the diagnosis and subsequent treatment of cancers.
Journal ArticleDOI
Prognostic Value of Preoperative Metabolic Tumor Volume and Total Lesion Glycolysis in Patients with Epithelial Ovarian Cancer
Hyun Hoon Chung,Hyun Woo Kwon,Keon Wook Kang,Noh-Hyun Park,Yong Sang Song,Yong Sang Song,June Key Chung,Soon-Beom Kang,Jae Weon Kim +8 more
TL;DR: Pretreatment metabolic parameters such as MTV and TLG showed statistically significant association with recurrence in patients with EOC and can be useful quantitative criteria for disease prognostication in patientsWith EOC before treatment.
Journal ArticleDOI
Hybrid imaging (SPECT/CT and PET/CT): improving therapeutic decisions.
TL;DR: PET/CT and SPECT/CT fusion images affect the clinical management in a significant proportion of patients with a wide range of diseases by guiding further procedures and changing both inter- and intramodality therapy, including soon after treatment has been initiated.
Journal ArticleDOI
Computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymph nodes in patients with ovarian cancer: a meta-analysis
TL;DR: FDG-PET or FDG- PET/CT is more accurate than CT and MR imaging in the detection of lymph node metastasis in patients with ovarian cancer.
Journal ArticleDOI
The Role of 18F-FDG PET in Assessing Therapy Response in Cancer of the Cervix and Ovaries
TL;DR: Preliminary data suggest that the addition of 18F-FDG PET/CT to the evaluation of patients with suspected recurrent ovarian carcinoma changes management in approximately a third and reduces overall treatment costs by accurately identifying patients who will or will not benefit from surgery.
References
More filters
Journal ArticleDOI
Cancer statistics, 2007.
TL;DR: While the absolute number of cancer deaths decreased for the second consecutive year in the United States, much progress has been made in reducing mortality rates and improving survival, cancer still accounts for more deaths than heart disease in persons under age 85 years.
Journal ArticleDOI
Cancer statistics, 2001.
TL;DR: Estimates of the number of new cancer cases and deaths expected in the US in the current year and the most recent data on cancer incidence, mortality, and survival reveal large disparities in cancer incidence and mortality across racial/ethnic groups.
Journal ArticleDOI
Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
William P. McGuire,William J. Hoskins,William J. Hoskins,Mark F. Brady,Paul R. Kucera,Edward E. Partridge,Katherine Y. Look,Daniel L. Clarke-Pearson,Martin Davidson +8 more
TL;DR: In this paper, the authors compared two combinations, cisplatin and cyclophosphamide and paclitaxel, in women with ovarian cancer, and found that the alkylating agent and a platinum coordination complex have high response rates in advanced ovarian cancer.
Journal ArticleDOI
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
John P. Neoptolemos,Deborah D. Stocken,Helmut Friess,Claudio Bassi,Janet A. Dunn,Helen Hickey,Hans G. Beger,Laureano Fernández-Cruz,Christos Dervenis,François Lacaine,Massimo Falconi,Paolo Pederzoli,Akos F. Pap,David Spooner,David J. Kerr,Markus W. Büchler +15 more
TL;DR: Adjuvant chemotherapy has a significant survival benefit in patients with resected pancreatic cancer, whereas adjuvant chemoradiotherapy has a deleterious effect on survival.